Hormone replacement therapy

Irresponsible to modify current guidelines

BMJ 2008; 337 doi: 10.1136/bmj.a1494 (Published 3 September 2008)
Cite this as: BMJ 2008;337:a1494

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ellen C G Grant, physician and medical gynaecologist1
  1. 1Kingston upon Thames KT2 7JU
  1. ellengrant{at}talktalk.net

    In the WISDOM hormone replacement therapy (HRT) trial, overall health related quality of life measures were reduced at four and 14 weeks of HRT use rather than increased (see table 4).1 Data were …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL